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Abstract
The NLR gene family mediates host immunity to various acute pathogenic stimuli, but its role in chronic infection is not
known. This paper addressed the role of NLRP3 (NALP3), its adaptor protein PYCARD (ASC), and caspase-1 during infection
with Mycobacterium tuberculosis (Mtb). Mtb infection of macrophages in culture induced IL-1b secretion, and this requires
the inflammasome components PYCARD, caspase-1, and NLRP3. However, in vivo Mtb aerosol infection of Nlrp3
2/2, Casp-
1
2/2, and WT mice showed no differences in pulmonary IL-1b production, bacterial burden, or long-term survival. In
contrast, a significant role was observed for Pycard in host protection during chronic Mtb infection, as shown by an abrupt
decrease in survival of Pycard
2/2 mice. Decreased survival of Pycard
2/2 animals was associated with defective granuloma
formation. These data demonstrate that PYCARD exerts a novel inflammasome-independent role during chronic Mtb
infection by containing the bacteria in granulomas.
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Introduction
Mycobacterium tuberculosis (Mtb) is the causative agent of
tuberculosis, a disease affecting one-third of the world’s population
and killing 1.7 million people each year [1]. Mtb is spread by
aerosol droplets from persons with active infection. Upon
inhalation, Mtb travels to the lung where it infects resident
alveolar macrophages [2]. This initial infection leads to an innate
immune response, which includes stimulation of Toll-like receptors
(TLRs) that recognize pathogens and are located on the plasma
membrane and within endosomes of host cells. Mtb is specifically
recognized by TLRs 2, 4, and 9 [3]. TLR activation upregulates
transcription of proinflammatory cytokines interleukin-1b (IL-1b),
tumor necrosis factor alpha (TNFa), and interleukin-6 (IL-6),
which are essential for the recruitment of immune cells to the site
of infection and controlling Mtb infection [4,5,6].
In addition to TLR recognition, a newly discovered class of
intracellular danger sensing proteins, the nucleotide binding
domain, leucine rich repeats-containing family proteins known
as NLRs, sense pathogens and pathogen products in the cell
cytoplasm [7]. With more than twenty members, the NLRs
function in host protection against a broad range of danger signals.
Several NLRs function in immunity through the formation of a
mutli-protein complex known as an inflammasome [8]. When
activated by a specific danger signal, the inflammasome forms and
results in recruitment and processing of pro-caspase-1, which in
turn processes IL-1b and IL-18 to their active forms for secretion
from macrophages.
NLRP3 is the most characterized of all the NLR inflamma-
some-forming proteins due to its abundant expression in
macrophages and activation in response to the largest number of
identified stimuli. In humans, a gain of function mutation in
NLRP3 is associated with hyperinflammatory hereditary periodic
fever syndromes with symptoms ranging from mild rash to severe
joint swelling [9].
Apoptotic speck-like protein containing a CARD domain (ASC,
also PYCARD) was originally identified as a speck-forming protein
during apoptosis of HL-60 cells [10]. PYCARD has also been
recognized as an adaptor protein that interacts with NLR proteins
forming a protein inflammasome structure resulting in caspase-1
processing and subsequent IL-1b and IL-18 activation [11].
PYCARD has been identified as an adaptor protein for NLRP3
and NLRP1, and it is functionally required for the NAIP5 and
NLRC4 inflammasomes [12]. Each inflammasome responds to a
specific set of stimuli, although there is some redundancy between
NLRs. Together, PYCARD, NLRP3, and caspase-1 are essential
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stimuli including bacteria [13,14] and viruses [15,16,17,18]. In
addition to these inflammatory functions, PYCARD association
with NLR proteins is required for pyroptotic and pyronecrotic cell
death [19,20]. Although the host’s innate immune response to Mtb
infection is critical for the initial defense against bacteria, the
adaptive immune response is ultimately required for containment
of the infection in the chronic stage of disease. Adaptive immunity
to Mtb infection is characterized by the appearance of antigen
specific CD4
+ T-cells that secrete interferon-gamma (IFN-c),
which is responsible for activating macrophages to kill intracellular
bacteria [21]. CD8+ T-cells are also important for controlling
bacteria during the chronic phase of Mtb infection [22]. Chronic
Mtb infection is controlled by granuloma formation which
contains, but does not eliminate bacteria [23]. Granulomas consist
of a central core of Mtb-infected macrophages surrounded by
successive waves of activated macrophages, giant multinucleated
cells, epithelioid cells, lymphocytes, fibroblasts, and dendritic cells.
A subset of granulomas undergoes central caseous necrosis due to
proteinaceous dead cell mass. Mice form slightly different
granulomas that do not form caseous necrotic centers, but
otherwise possess the same cell types and similar granuloma
organization to humans [24].
Pro-inflammatory cytokine regulation can be critical to long-
term survival of Mtb infection. In vivo assessments of IL-1a/b
2/2,
IL-1R
2/2, and IL-18
2/2 mice have shown that these cytokines
play a role in limiting bacterial lung burden, regulating other
cytokines, nitric oxide production, and forming organized
granulomas [25,26,27]. Likewise, mice deficient in pro-inflamma-
tory cytokines IL-6 and TNFa have increased mortality during
Mtb infection [4,5]. TNFa is important for granuloma formation
and maintenance [28]. Therefore, these cytokines are not only
important in the innate immune response to Mtb, but also in host
defense during chronic Mtb infection.
High interest in the role of NLRs in host immunity has led to
the study of inflammasome complexes in response to many
pathogens. The research thus far has almost exclusively focused on
the acute effects of pathogens and other NLR stimuli. Conse-
quently, the in vivo role of the NLR inflammasome during chronic
infection has not been studied. Mtb infection exemplifies a chronic
infection of paramount public health interest. Mtb infects
macrophages where it must thwart the host immune response to
survive and replicate. Nlrp3 inflammasome proteins are expressed
in macrophages; thus, we hypothesized that Mtb infection would
induce inflammasome activation. Here we show that Mtb induced
IL-1b secretion in human and mouse macrophages in vitro and this
process was dependent on PYCARD, caspase-1, and NLRP3, but
not NLCR4. In vivo, murine Pycard helps protect the host from
death during chronic Mtb infection while the effects of Casp-1 and
Nlrp3 were negligible. The inability of Pycard
2/2 mice to form
organized granulomas and the reduced presence of lung dendritic
cells indicates a breakdown in host defense against Mtb. Thus, we
identify PYCARD as a critical protein involved in host response to
Mtb infection in an inflammasome-independent manner.
Results
Virulent and attenuated Mtb require PYCARD, NLRP3, and
caspase-1 for IL-1b secretion by cultured human cells
During human Mtb infection, bacteria travel to the alveolar
spaces where they infect and replicate inside macrophages.
Secretion of IL-1b by macrophages requires pro-IL-1b processing
by caspase-1. Caspase-1 interaction with several NLR forming
inflammasomes results in caspase-1 processing, a prerequisite for
IL-1b activation [12]. To determine if host detection of Mtb
involves inflammasome activation, we used a used a panel of
human monocytic THP-1 cell lines with reduced expression of
inflammasome genes due to shRNA targeting sequences (Table
S1, Figure S1). During infection with the virulent Mtb strain
H37Rv, THP-1 cells with shPYCARD or shNLRP3 secreted
significantly less IL-1b than their scrambled controls (Figure 1A).
This indicates that Mtb activates the NLRP3 inflammasome. IL-18
is an inflammatory cytokine which induces cell-mediated immu-
nity and causes T-cells to secrete IFN-c [29]. Similar to IL-1b,i t
also requires caspase-1 cleavage for activation. IL-18 secretion
from Mtb-infected THP-1 cells was dependent on PYCARD and
NLRP3 (Figure 1B). These data demonstrated that both IL-1b
and IL-18 were processed during Mtb infection and that each
required the NLRP3 inflammasome formation for activation in
the THP-1 human monocytic cell line.
As seen with H37Rv, the attenuated Mtb H37Ra strain induced
IL-1b secretion from THP-1 cells in a PYCARD- and NLRP3-
dependent manner. Induction of IL-1b by H37Ra was dependent
on the NLRP3 inflammasome (Figure 1C). We consistently
observed more IL-1b secretion in THP-1 cells infected with
H37Ra, although the difference was not statistically significant.
Thus, the NLRP3 inflammasome is activated by both virulent and
attenuated Mtb. Chemically inhibiting caspase-1 with caspase-1-
specific inhibitor Y-VAD significantly reduced IL-1b secreted by
THP-1 cells, confirming the necessity of caspase-1 cleavage for IL-
1b secretion (Figure 1D).
Production of IL-1b in Mtb infected primary mouse
macrophages is Pycard, Nlrp3, and Casp-1 dependent
To confirm our THP-1 data that the inflammasome is necessary
for IL-1b processing, we infected primary mouse macrophages from
gene depletion mice. We infected either bone-marrow derived
(BMDM) or thioglycolated elicited macrophages with Mtb. Mtb-
induced IL-1b secretion in wild type macrophages, confirming the
results we obtained with THP-1 cells. Mtb-infected BMDM from
Pycard
2/2, Nlrp3
2/2,a n dCasp-1
2/2 mice had significantly reduced
IL-1bsecretion,indicatingthattheNlrp3-inflammasomeisnecessary
for Mtb-induced IL-1b secretion in macrophages. Nlrc4
2/2 BMDM
secreted IL-1b at the same or higher levels compared to wild type,
indicating this inflammasome is not involved in the host response to
Mtb (Figure 2A). This demonstrates congruent findings using THP-
1 cells and primary mouse macrophages.
Induction of the NLRP3 inflammasome was not limited to
virulent Mtb H37Rv infection, but also occurred with attenuated
Mtb H37Ra (Figure 2B). Wild type BMDM infected with Mtb
H37Ra secreted abundant amounts of IL-1b while Pycard
2/2 and
Nlrp3
2/2 macrophages did not. Our findings were repeated in
primary thioglycolate elicited macrophages. These highly activat-
ed macrophages had a significant reduction in IL-1b secretion in
the absence of Pycard and Nlrp3 (Figure 2C), reinforcing our data
from human THP-1 cells and BMDM infected with virulent and
attenuated Mtb. IL-18 secretion from both BMDM and thiogly-
colate elicited macrophages was below the level of detection for all
samples tested. In cultured human monocytes and primary mouse
macrophages Mtb induced IL-1b and IL-18 secretion in the
absence of cell priming. This indicates that Mtb upregulates both
transcription and processing of these proinflammatory cytokines in
vitro. Taken together, our data show that the ability of Mtb to
induce IL-1b secretion was PYCARD, NLRP3, and caspase-1
dependent in human THP-1 cells as well as primary mouse
macrophages. In contrast, NLRC4 did not affect IL-1b produc-
tion, indicating that Mtb induces a host response through the
NLRP3, but not the NLRC4, inflammasome.
PYCARD Protects against Mtb
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Mtb infection
Lack of IL-1b in vivo has been previously shown to be important
for response to Mtb infection resulting in increased lung bacterial
burden, differential regulation of cytokines, and defects in
granuloma formation [6,26]. Given our data from infecting
cultured cells, we hypothesized that mice lacking the Pycard or
Nlrp3 would be unable to process IL-1b resulting in an inability to
control Mtb in vivo. To test this hypothesis, wild type, Pycard
2/2,
and Nlrp3
2/2 animals were infected with aerosolized Mtb H37Rv.
Figure 2. Mtb induced Pycard, Nlrp3, and Casp-1 dependent IL-1b release in primary macrophages. A. Pycard
2/2, Nlrp3
2/2, and Casp-1
2/2
BMDM have decreased levels of IL-1b in response to Mtb H37Rv infection compared to WT or untreated (NT) BMDM. B. Attenuated Mtb H37Ra induced
Pycard and Nlrp3-dependent IL-1b release. C. Thioglycolate elicited macrophages infected with Mtb H37Rv and Mtb H37Ra induced Pycard and Nlrp3-
dependent IL-1b release. Error bars represent SD of a representative experiment. Each experiment was repeated a minimum of three times. * p,0.05.
doi:10.1371/journal.pone.0012320.g002
Figure 1. Mtb induced IL-1b in a human monocytic cell line required PYCARD and NLRP3. A. Virulent Mtb H37Rv induced IL-1b release was
decreased in THP-1 cells stably transduced with PYCARD and NLRP3-specific shRNAs (shPYCARD and shNLRP3, respectively) but not in cells
transduced with an empty vector (EV) or scrambled shRNAs (mut) or untreated (NT) cells. B. Mtb-induced IL-18 secretion was observed in EV and mut
controls but not in shPYCARD and shNLRP3 cells. C. Attenuated Mtb H37Ra induced PYCARD and NLRP3-dependent IL-1b release. D. Caspase-1
specific inhibitor (YVAD-CHO, 100 mM) blocked Mtb-induced IL-1b. Error bars represent SD of a representative experiment. All experiments were
repeated a minimum of three times. ** p,0.001.
doi:10.1371/journal.pone.0012320.g001
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first four-and-a-half months, survival of wild type and Pycard
2/2
mice was similar. However, Pycard
2/2 mice had a survival defect
thereafter, and they died precipitously between 143 and 155 days
post-infection with a mean survival of 148 days (Figure 3A). By
comparison, wild type mice infected with Mtb had a mean survival
of 200 days. These results were confirmed in a two additional
experiments (not shown). Death of Pycard
2/2 mice during Mtb
infection was not due to advanced age as we routinely keep
Pycard
2/2 breeder pairs for up to a year with no unexplained
deaths. This strong survival phenotype shows that Pycard is
important for host defense against virulent Mtb infection in vivo.
PYCARD is an adaptor protein that is required for several NLR
proteins to form inflammasomes. Since our in vitro data indicated
NLRP3 was necessary for Mtb induction of IL-1b in macrophages,
we also investigated survival of Nlrp3
2/2 mice during aerosolized
Mtb infection. Although NLRP3 is important for IL-1b secretion
from cultured macrophages, there was no difference in survival of
Nlrp3
2/2 mice in vivo (Figure 3B). Overall, Nlrp3
2/2 mice had a
mean survival of 209 days compared to 212 days for wild type
mice. This data was also confirmed in a second experiment (not
shown). In a separate experiment, we tested the ability of another
closely related NLR gene, Nlrc4, to protect the host from Mtb.
Nlrc4
2/2 mice had a similar survival profile to paired wild type
controls, with a mean survival of 190 days compared to 198 days
for wild type controls (Figure 3C). These data indicate that
elimination of Pycard, but not Nlrp3 nor Nlrc4, resulted in a reduced
ability of the host to defend against Mtb infection.
Pycard and Nlrp3 do not significantly affect Mtb bacterial
burden
Prior in vivo studies show that Mtb has two phases of infection
[30]. In the first three weeks following aerosol infection, Mtb grows
logarithmically in the lungs. After three weeks of infection, an
effective Th1 adaptive immune response is established and the
exponential growth of Mtb ends. Mtb bacterial burden in the lungs,
spleen, and liver persist at the same level for the remainder of the
infection [31]. We assessed bacterial burden in the lungs of
Pycard
2/2 and Nlrp3
2/2 mice in two separate infections, with each
compared to paired C57BL/6 controls. Animals lacking Pycard
and Nlrp3 have similar levels of bacteria in the lungs during the
growth and persistence phases of Mtb infection compared to wild
type (Figure 3D, G). The last time points were taken as Pycard
2/2
and Nlrp3
2/2 mice neared death. We saw no statistical difference
between the bacterial burden of lungs from Pycard
2/2, Nlrp3
2/2,
or wild type mice. The bacterial burden in the liver and spleen of
the Pycard
2/2 and Nlrp3
2/2 mice was also similar to that found in
wild type mice, indicating that Pycard and Nlrp3 do not affect
bacterial dissemination (Figure 3E–F, H–I). Thus, a change in
Figure 3. Pycard
2/2 mice were more susceptible to Mtb H37Rv aerosol infection, but bacterial burden was not increased. A. Pycard
2/2
mice infected with Mtb H37Rv die significantly earlier than age and sex matched wild type mice (**p,0.0001, log rank) B–C. No significant difference
in survival was observed between Nlrp3
2/2 or Nlrc4
2/2 and WT mice after Mtb H37Rv infection. D–I. Bacterial organ burden. (D,G) Lungs, (E,H) liver,
and (F,I) spleen of Mtb-infected Pycard
2/2 (D–F) and Nlrp3
2/2 (G–I) mice. Each gene-deletion mouse was individually controlled by concurrent
infection of wild type mice. Error bars represent SD of a representative experiment. Organ burden data were obtained from two or more independent
experiments with each containing at least three mice per genotype per time point.
doi:10.1371/journal.pone.0012320.g003
PYCARD Protects against Mtb
PLoS ONE | www.plosone.org 4 August 2010 | Volume 5 | Issue 8 | e12320bacterial burden and dissemination cannot explain the different
survival rate of Pycard
2/2 compared to WT or Nlrp3
2/2 mice.
Pro-inflammatory cytokines are produced at similar levels
in the lungs of wild type, Pycard
2/2, and Nlrp3
2/2 mice
following Mtb H37Rv aerosol infection
Our earlier studies led us to hypothesize that less IL-1b would
be produced in the lungs of Pycard
2/2 and Nlrp3
2/2 mice
compared to wild type because the gene deletion mice would not
be able to cleave pro-IL-1b to its active form in response to Mtb
infection. To test this, cytokines were measured from tissue free,
homogenized lung extract by ELISA. Surprisingly, we found all
three groups of animals produced IL-1b in similar amounts. IL-1b
levels increased during the logarithmic growth phase of infection
and were still high during the persistence phase of infection
(Figure 4A). By week 16, levels of IL-1b decreased slightly. There
was no significant reduction in IL-1b secretion between Pycard
2/2
and Nrp3
2/2 mice compared to wild type at any of the time points
we measured. Because of the mechanical nature of lung
homogenization, cells are broken open in the process which could
result in release of both pro and cleaved IL-1b in the lung
homogenate extracts. We performed IL-1b western blots in
addition to ELISAs to ensure we were measuring the amount of
cleaved IL-1b produced in the lungs of Mtb-infected animals
in vivo. At one week post-infection, as expected, only pro-IL1b was
present (Figure 4B, top panel). At 16 weeks post-infection,
Pycard
2/2 and Nlrp3
2/2 animals produced comparable if not
enhanced levels of cleaved IL-1b compared to wild type mice
(Figure 4B, bottom panel). The amount of IL-1b was
reproducible between mice and correlates with the ELISA data.
These data show that differences in IL-1b production cannot
explain differences in the survival rate of Pycard
2/2 compared to
WT or Nlrp3
2/2 animals. We also measured pro-inflammatory
cytokines IL-6 and TNFa. TNFa is of particular interest as it is
important for granuloma formation and the control of infection in
Mtb-infected animals and humans [5,28]. IL-6 has also been
shown to be an important host response against Mtb [4].
Furthermore, a previous report showed that human PYCARD is
required for TNFa and IL-6 expression upon bacterial infection
[32]. Both cytokines followed similar trends as IL-1b with total
cytokine levels rising during early infection and then dropping off
significantly by week 16 (Figure 4C and D). Nlrp3
2/2 mice had a
modest but statistically significantly increase in IL-6 and TNF-a
cytokines at 2 weeks (p=0.026 and p=0.028, respectively) and 5
weeks post-infection (p=0.004, p=0.001, respectively), but all
differences were diminished by 16 weeks post-infection. There
were no significant differences in lung cytokine levels between
Pycard
2/2 and wild type mice at any time points analyzed.
Proinflammatory cytokines in serum and bronchoalveolar lavage
fluid were below the level of detection. These data indicate that
reduced TNFa and IL-6 are not correlated with increased death in
Mtb-infected Pycard
2/2 mice.
Caspase-1 is not required for survival, bacterial
containment, or the production of proinflammatory
cytokines in Mtb infected mice
Caspase-1 recruits and cleaves IL-1b to its active form and is
common to all NLR inflammasomes. A previous report has
shown that at a low infectious unit of influenza virus, viral-
induced host response is mediated by an Nlrp3-independent but
Pycard/Casp-1-dependent inflammasome [15]. To assess if Cas-
pase-1 and Pycard together mediate host protection in the
context of inflammasome activation, we investigated the contri-
bution of Caspase-1 during Mtb infection. Infection of Casp-1
2/2
mice with Mtb produced no difference in survival compared to
wild type mice (Figure 5A). Measurement of bacterial burden
showed that Casp-1
2/2 and wild type mice had similar levels of
bacteria in the lungs over the course of Mtb infection (Figure 5B).
Casp-1
2/2 and wild type mice also had similar bacterial burden
in the liver and spleen, indicating that bacterial dissemination and
growth in these organs are comparable between genotypes
(Figure 5C). Overall, these data indicate that Caspase-1 does
Figure 4. During Mtb infection wild-type, Pycard
2/2 and Nlrp3
2/2 mice produced similar levels of mature IL-1b. Lung homogenates
were assayed for proinflammatory cytokines. A–B. IL-1b was present in the lungs of Pycard
2/2 and Nlrp3
2/2 mice by ELISA (A) and western blot (B)
one week (B, top panel) and 16 weeks (B, bottom panel) post aerosol infection. Each number represents a different mouse. C–D. IL-6 (C) and
TNFa (D) were modestly increased in Nlrp3
2/2 lungs compared to Pycard
2/2 and WT. Cytokine measurements were taken from at least three mice
per genotype per time point in two independent experiments. *p,0.05.
doi:10.1371/journal.pone.0012320.g004
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Hence, this work describes a novel Pycard-dependent but Casp-1-
independent form of host immunity.
Caspase-1 cleaves pro-IL-1b to its biologically active form.
However, our earlier results demonstrated that cleaved IL-1b
levels were similar in Pycard
2/2, Nlrp3
2/2, and Nlrc4
2/2 lungs. An
analysis of Casp-1
2/2 mice show that rather than diminished IL-
1b, they had increased lung IL-1b in their lungs compared to wild
type as measured by ELISA (Figure 5D). We utilized western
blots to measure both the pro- and cleaved forms of IL-1b from
lung homogenate extracts collected one week and 20 weeks post
infection. At one week post infection only low levels of pro-IL-1b
were present in the Casp-1
2/2 and wild type lungs (Figure 5E,
top panel). At 20 weeks post infection pro- and cleaved IL-1b
were present in both Casp-1
2/2 and wild type mouse lungs with
more found in the former (Figure 5E, bottom panel). These
data demonstrate that Casp-1
2/2 mice have compensatory
mechanisms of cleaving IL-1b in the absence of caspase-1. Levels
of IL-6 and TNF-a also were unchanged between Casp-1
2/2 and
wild type lungs (Figure 5F–G). Overall our in vivo characteriza-
tion of the Casp-1
2/2 mouse reveals that Caspase-1 does not play
a prominent role in host protection against Mtb. This supports the
conclusion that protective host immunity to Mtb is independent of
the inflammasome.
Pycard
2/2 mice form fewer granulomas
To further explore the mechanism by which Pycard enhances
survival in chronically infected mice, we examined the histopa-
thology of Mtb-infected mouse lungs. We examined granuloma
structure because of its role in containing bacteria during chronic
Mtb infection [23] and because Pycard
2/2 mice exhibit an abrupt
drop in survival during the chronic phase of infection. We assessed
lung inflammation 16 weeks post infection by measuring the
amount of inflamed tissue from each mouse lung (see experimental
procedures). Low magnification images showed that the alveolar
spaces of wild type, Pycard
2/2, Nlrp3
2/2, and Casp-1
2/2 mice
were obstructed by an influx of immune cells into the lung. We
found the lungs of all our gene depletion and wild type mice to be
highly inflamed, ranging from 90–98 percent of the total lung
tissue (Figure 6A–B). In all infected mice, we observed dense
areas of immune cells, indicative of granulomatous lesions.
Strikingly, the Pycard
2/2 animals formed significantly fewer
Figure 5. Casp-1 was not protective during Mtb infection. A. Casp-1
2/2 mice infected with Mtb did not have a difference in survival compared
to wild type mice. B–C. Bacterial burden in the lungs, liver, and spleen was comparable between Casp-1
2/2 and wild type mice. D–G. Lung
homogenates were assayed for proinflammatory cytokines. D. Casp-1
2/2 lungs contained significantly more IL-1b than wild type lungs by ELISA
(* p,0.05). E. IL-1b was confirmed by western blot of lung homogenates one week (E, top panel) and 20 weeks (E, bottom panel) post aerosol
infection. F–G. There were no differences in the amount of IL-6 (F) or TNFa (G) present in Casp-1
2/2 and wild type lungs. Cytokine measurements
were taken from at least three mice per genotype per time point in two independent experiments.
doi:10.1371/journal.pone.0012320.g005
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2/2, and Casp-
1
2/2 lungs (Figure 6C–D). Examination under higher magnifi-
cation showed that wild type and Nlrp3
2/2 mice formed similar
sized granulomas. Hence, Pycard affected the formation of
granulomas, but once they were formed, granuloma size was not
affected by this gene (Figure 6E–F). Casp-1
2/2 mice formed
larger granulomas, although this did not affect the outcome of
infection. To further assess the lung granuloma defect in Pycard
2/2
mice, we stained mouse lung sections with Ziehl Neelsen stain to
identify Mtb. Earlier data showed that the overall lung bacterial
burden was similar in wild type and Pycard
2/2 mice by bacterial
plating of homogenized lungs (Figure 3F–G). In contrast, analysis
of acid fast staining revealed striking differences in bacterial
localization in wild type and Pycard
2/2 lungs. Acid fast staining of
wild type lungs shows very little Mtb located in non-granulomatous
lung tissue. In contrast, Pycard
2/2 mice contain bacteria
Figure 6. Pycard
2/2 mice had fewer lung granulomas and were unable to contain bacteria within granulomas during chronic Mtb
infection. Histopathological analysis of lungs 16 weeks post Mtb infection. A–B. Whole lung images showed similar percentages of inflamed lung
tissue in all genotypes of Mtb-infected mice. C–D.4 0 6images demonstrate that Pycard
2/2 mice form significantly fewer granulomas compared to
wild type, Nlrp3
2/2, and Casp-1
2/2 mice (* p,0.05). E–F. 4006images demonstrate wild type, Pycard
2/2, and Nlrp3
2/2 mice form similarly sized
granulomas while Casp-1
2/2 mice form significantly larger granulomas (**p,0.001). G–H. Images of acid-fast stained lung sections from non-
granulomatous regions of Mtb-infected lung tissue were taken at 1006and 4006. Pycard
2/2 mice have bacterial located throughout the lung unlike
wild type mice in which bacteria is mainly contained within granulomas (*p,0.01). To view bacteria within a single macrophage, 10006images were
cropped, and enlarged. Quantification was performed on sections from 4–8 mouse lungs per genotype from two independent experiments.
doi:10.1371/journal.pone.0012320.g006
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in tissue that is not associated with granulomas (Figure 6G). The
amount of bacteria located outside of the granuloma was
quantified by using a scale of 0–4 based on the amount of
bacteria present in lung tissue that was not associated with
granulomas (see experimental procedures) (Figure 6H). Pycard
2/2
mice form significantly fewer lung granulomas than wild type
mice. The acid-fast staining data demonstrate that Pycard
2/2
animals were unable to contain bacteria within granulomas, shown
by massive amounts of Mtb located in non-granulomatous lung
tissue compared to wild type mice. Reduced granulomas in the
lungs of Pycard
2/2 provide plausible mechanisms to explain the
decreased lifespan observed in these animals during chronic Mtb
infection.
Discussion
In this report, we focus on the ability of virulent Mtb to stimulate
inflammasome activation and the role of the inflammasome in host
defense against Mtb. Prior studies have implicated the inflamma-
some in mycobacterium infection in vitro. Consistent with our data,
one report showed that M. marinum, a mycobacterium that
naturally infects fish and amphibians, activates IL-1b production
in a PYCARD, NLRP3, and caspase-1-dependent manner in vitro,
but no in vivo investigation was conducted [33]. Another report
showed that M. bovis BCG, the vaccine strain of Mtb, can limit
caspase-1 and IL-1b activation due to a putative protease Zmp1.
In this latter study, however, there was no analysis of Pycard, Nlrp3
or Nlrc4 to directly implicate the inflammasome components [34].
A third report showed that Mtb infected THP-1 human monocyte
cell line secrete IL-1b in a PYCARD and NLRP3-dependent
process, but did not investigate the role of the inflammasome in vivo
[35].
Our study showed that virulent Mtb H37Rv, along with the
attenuated derivative Mtb H37Ra, induced NLRP3, PYCARD,
and caspase-1-dependent inflammasome activation in a human
macrophage cell line and in primary mouse macrophages.
However, these in vitro results do not predict the outcome in mice.
Most importantly, our study showed that Pycard is important for
host protection during chronic infection with virulent Mtb infection
in vivo, demonstrated by decreased survival of Pycard
2/2 mice
compared to wild type controls. Pycard did not confer a survival
advantage through the production of IL-1b. Rather it functions to
prolong host survival through a novel inflammasome-independent
role likelythroughproper granulomaformationduringchronicMtb
infection.Surprisingly, neither Nlrp3 norCasp-1 played a prominent
role in host protection during Mtb infection despite its importance
in culture. The inconsistencies between the in vitro and in vivo role of
Nlrp3 and Casp-1 underscores the absolute necessity for in vivo
validation in relating host immune genes to the outcome of
microbial infections.
IL-1b cleavage is a hallmark of inflammasome activation, and
we observed significant Pycard, Nlrp3,a n dCasp-1-dependent
inflammasome activation during in vitro infection of cultured
cells. However, in our in vivo studies, we observed mature IL-1b
in the lungs of Mtb infected wild type, Pycard
2/2, Nlrp3
2/2,a n d
Casp-1
2/2 mice. This, along with mouse survival data, indicates
that Pycard host protection during Mtb infection in vivo is
inflammasome independent. The similar survival profiles of
Nlrp3
2/2 and Casp-1
2/2 mice compared to wild type mice may
be due to compensatory mechanisms of IL-1b processing. It is
i m p o r t a n tt on o t et h a tt h ei n f l ammasome is not the only host
mechanism for cleaving pro-IL-1b to its active form. Through
less well established, caspase-1-independent IL-1b cleavage can
be carried out by several other host proteases including
granzyme A, chymase, chymotrypsin, and matrix metallopro-
teinases as well as bacterial enzymes [36,37,38,39]. Meanwhile,
Pycard
2/2 mice lacked an additional mechanism to form or
maintain granulomas thereby compromising their resistance to
Mtb infection.
To investigate the mechanism further, we show that Pycard
2/2
mice have fewer lung granulomas compared to wild type, Nlrp3
2/2,
or Casp-1
2/2 mice, despite having the same amount of inflamed
lung tissue. Acid-fast staining for Mtb localization within the lung
demonstrated that Pycard
2/2 mice are defective in containing Mtb
within granulomas, as shown by large amounts of bacteria found
in non-granulomatous lung tissue. In comparison, infected wild
type mice have almost no bacteria found outside of granulomas.
Our data show that overall the lungs of Pycard
2/2 and wild type
mice have the same amount of bacteria. However, the
localization of Mtb within the lung is radically different. These
data support a working hypothesis that Pycard affects proper cell
accumulation during chronic Mtb infection and promotes proper
granuloma formation.
Recently, another group implicated an inflammasome-indepen-
dent role for Pycard in host protection against Mtb in vivo [40]. In
contrast to our data, this paper found that Casp-1 deficient mice
had decreased survival during Mtb infection. This may be due to
differences in the amount of bacteria delivered to the mice or
mouse housing conditions. Nonetheless, both their and our papers
come to the same conclusion: that Pycard has a role in host
protection independent of Nlrp3.
In summary, this work demonstrates that PYCARD promotes
survival during the late phase of Mtb infection independent of
inflammasome activation. This result also highlights the impor-
tance of PYCARD in the process of granuloma formation during
chronic Mtb infection. Considering the high rates of chronic Mtb
infection worldwide and the increasing number of multi-drug
resistant and extensively drug resistant tuberculosis cases, our
study suggests that understanding the role of PYCARD during Mtb
infection may lead to new and more effective therapies to treat
chronic Mtb infection. In contrast, the lack of a role for NLRP3
and caspase-1 in the in vivo containment of Mtb is encouraging for
the development of inhibitors for autoinflammatory disorders.
These results suggest that anti-NLRP3 and caspase-1 strategies are
not likely to cause the inadvertent activation of latent Mtb infection
in patients.
Methods
Ethics statement
All studies were conducted in accordance with the National
Institutes of Heath Guide for the Care and Use of Laboratory
Animals and were approved by the Institutional Animal Care and
Use Committee (IACUC) guidelines of the University of North
Carolina at Chapel Hill (protocol #07-170 and 09-195).
shRNA knockdown THP-1 cell lines
THP-1 cells were obtained from ATCC. Generation of shRNA
knockdown and control vectors for PYCARD and NLRP3 have
been described previously [13,32]. All shRNA hairpins were
confirmed by sequencing (Table S1). Lentiviral packaging and
transduction of THP1 cells has been previously described [41].
Verification by RT-PCR indicated a significant reduction in
PYCARD and NLRP3 expression (Figure S1 A–B). Functionally,
shPYCARD and shNLRP3 had reduced IL-1b production in
response to LPS (Figure S1C).
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Mtb H37Rv and H37Ra were obtained from the laboratory of
William R. Jacobs, Jr. [42] and ATCC, respectively. Bacteria were
grown to log phase in Middlebrook 7H9 broth (Difco) with 0.2%
glycerol, 16 albumin dextrose saline, and 0.05% Tween 80.
Inoculum was assessed by plating infection media on Middlebrook
7H10 agar plates supplemented with glycerol and ADS as
described above. Colony forming units (cfu) were counted after
21 days of incubation.
Mtb infection of cultured cells
Cell lines were cultured in RPMI (Gibco) with 10% FBS
(Hyclone). Bone marrow derived macrophages were harvested
from 6- to 8-week-old mouse femurs and cultured for 6 days in
DMEM supplemented with L-glutamine, non-essential amino
acids, 10% fetal bovine serum, and 20% L929 conditioned media.
Thioglycolate elicited macrophages were obtained by peritoneal
lavage 4 days after intraperitoneal injection with 3% thioglycolate
and cultured in DMEM supplemented as above. All cells were
infected under BSL3 conditions with Mtb H37Rv or H37Ra at an
MOI of 10 and incubated for 8 hours at 37uC with 5% CO2. Cell-
free supernatants were harvested, double filtered with 0.2 m filters,
and assayed for cytokines by ELISA and western blot.
Mtb H37Rv aerosol infection of mice
Generation of Pycard
2/2, Nlrp3
2/2, Casp-1
2/2, and Nlrc4
2/2
mice [43,44,45] have been described previously and were
backcrossed onto C57BL/6 (Jackson Lab) background for a
minimum of 9 generations. Mice were routinely genotyped.
Female Pycard
2/2, Casp-1
2/2 Nlrp3
2/2,and Nlrc4
2/2 mice and
age matched C57BL/6 female controls were infected via aerosol as
previously described [46]. Mice received 250–350 colony forming
units per lung, determined by sacrificing a subset of mice 1d post
infection as described by others [46]. Bacterial organ burden was
quantified by plating serial dilutions of lung, liver, and spleen
homogenates on 7H10 plates containing cycloheximide (1 mg/ml)
and carbenicillin (50 mg/ml) to minimize contamination. Animal
infections and organ harvests were carried out under BSL3
conditions.
Cytokine determination
Cytokines were measured from infected cell supernatants with
human or mouse BD OptEIA IL-1b, TNFa, and IL-6 ELISA Sets
(BD Biosciences) and IL-18 ELISA (MBL International). In vivo
cytokines were measured from lung homogenate extracts by
centrifuging homogenized lung tissue to create a tissue-free
supernatant. Amounts of pro- and cleaved IL-1b in lung
homogenate extracts were determined by western blot. Immuno-
blots were probed with goat anti-mouse IL-1b primary antibody
(R&D Biosystems). Bands were visualized by Super Signal
Chemiluminescence (Pierce).
Histopathology
Lungs were fixed in 10% buffered formalin and stained with
H&E to evaluate airway inflammation and identify granulomas.
The percent of inflamed lung tissue was determined by dividing
the inflamed areas by the total lung area. Granuloma frequency
was determined by counting the number of granulomas present
in the total lung section. Granuloma size was measured by
defining the granuloma borders for 26 lesions using Image J
software and determining the average. Ziehl-Neelsen (ZN)
staining was used to determine bacterial localization. The entire
Mtb infected mouse lung was scored on a scale from 0–4: 0=no
bacteria found outside of granulomas, 1=1–5 bacteria found
outside of granulomas, 2=6–20 bacteria found outside of
granulomas, 3=approximately half of each field contains 20-50
bacteria outside of granulomas, and 4= greater than half of each
field contains greater than 50 bacteria outside of granulomas.
H&E lung sections were blindly scored by E.M., I.C.A., M.S.,
and P.H. ZN stained lung sections were blindly scored by M.S.
and P.H. For all histology quantification 4–8 mouse lungs per
genotype were analyzed.
Statistics
Data are presented as the means +/2 standard deviation (SD)
unless otherwise noted. Analysis Of Variance (ANOVA) followed
by Tukey-Kramer HSD for multiple comparisons was performed
on complex data sets. Statistical significance for single data points
was assessed by the Student’s two-tailed t-test. Survival curves
were generated utilizing the product limit method of Kaplan and
Meier and comparisons were made using the log rank test. In all
cases, a p-value of less than 0.05 was considered statistically
significant.
Supporting Information
Table S1 Target sequences for shRNA THP-1 cell lines. Target
sequences for PYCARD and NLRP3 shRNA hairpins used to
construct stable knockdown THP-1 cell lines.
Found at: doi:10.1371/journal.pone.0012320.s001 (0.03 MB
DOC)
Figure S1 Validation of shRNA THP-1 cell lines. A–B. To
ensure shRNA THP-1 cell lines had reduced gene expression we
measured PYCARD (A) and NLRP3 (B) gene transcript by RT-
PCR. C. Functional knockdown was shown by reduced IL-1b
production in shPYCARD and shNLRP3 THP-1 cell lines after
LPS stimulation. The THP cells used in this work have been cited
in two other papers [1,2]. These data are not included as new data
but intended to be confirmatory of previous work. 1. Taxman DJ,
Zhang J, Champagne C, Bergstralh DT, Iocca HA, et al. (2006)
Cutting edge: ASC mediates the induction of multiple cytokines by
Porphyromonas gingivalis via caspase-1-dependent and -indepen-
dent pathways. J Immunol 177: 4252–4256. 2. Willingham SB,
Bergstralh DT, O’Connor W, Morrison AC, Taxman DJ, et al.
(2007) Microbial pathogen-induced necrotic cell death mediated
by the inflammasome components CIAS1/cryopyrin/NLRP3 and
ASC. Cell Host Microbe 2: 147–159.
Found at: doi:10.1371/journal.pone.0012320.s002 (0.18 MB
DOC)
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